Targeting the VEGF Axis in Advanced NSCLC

ASCO, ASCO 2016 – Lung Cancer
Videos — July 6, 2016

Featuring:

Benjamin P. Levy, MD, reviews current and emerging roles for agents that target the VEGF axis in advanced non–small-cell lung cancer and expresses his belief that a lot of work needs to be done to define the optimal space for these drugs.

Related Articles

Redesigning Access: S2302 Pragmatica-Lung Study as a Model for Inclusive Cancer Trials
By Meg Barbor, MPH
ASCO, ASCO Conference, Clinical Trials
Web Exclusives
Read Article
Updated ASCO Guidelines Reiterate the Importance of Geriatric Assessment in Older Patients With Cancer
Oncology Practice, ASCO 2023 Highlights, Geriatric Cancer, ASCO
October 2023, Vol 14, No 5
Read Article
De-escalating Chemotherapy Possible in Low-Risk Patients with Advanced Testicular Cancer
By Wayne Kuznar
ASCO, Genitourinary Cancers
April 2020, Vol 11, No 2
Read Article
A Call to Focus on Financial Toxicity and Quality of Life in Genitourinary Malignancies
By Wayne Kuznar
ASCO, Genitourinary Cancers
April 2020, Vol 11, No 2
Read Article
MicroRNAs Have Promise as Biomarker in Testicular and Other Germ-Cell Tumors
By Wayne Kuznar
ASCO, Genitourinary Cancers
April 2020, Vol 11, No 2
Read Article
Gemcitabine-Cisplatin Combination a New Standard in Pancreatic Cancer with Germline BRCA or PALB2 Mutation
By Wayne Kuznar
ASCO, Gastrointestinal Cancers, Pancreatic Cancer
April 2020, Vol 11, No 2
Read Article
Encorafenib plus Cetuximab Improves Quality of Life versus Standard of Care in Colorectal Cancer Associated with BRAF Mutation
By Wayne Kuznar
ASCO, Colorectal Cancer, Gastrointestinal Cancers
April 2020, Vol 11, No 2
Read Article
Conquer Cancer Foundation of ASCO & Swim Across America Team Up To Create Young Investigator Award
ASCO 2019, In the News, ASCO
Web Exclusives
Read Article
Daratumumab in Combination with Carfilzomib, Lenalidomide, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma (MMY1001): An Open-Label Phase 1b Study 
ASCO 2017 – Multiple Myeloma, ASCO
Conference Correspondent
Read Article

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
Amplity
© Amplity, Inc. All Rights Reserved. Privacy Policy.

We Value Your Feedback! Tell Us How You Consume Content

Your feedback will help us tailor our content to better meet your needs and preferences.

*First Name
*Last Name
*Email
*What's your favorite format for experiencing our content?